Stay updated on LASER-TBM Clinical Trial
Sign up to get notified when there's something new on the LASER-TBM Clinical Trial page.

Latest updates to the LASER-TBM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of the LASER-TBM trial, specifically highlighting the standard of care anti-tuberculous therapy and the inclusion of Dexamethasone. Additionally, the trial's design has been clarified as a Phase IIA, randomized, active-controlled, open-label, parallel-group trial.SummaryDifference37%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to LASER-TBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LASER-TBM Clinical Trial page.